This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 53/5/812    most recent HYPERTENSIONAHA.108.127977v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Poon, L. C.Y. Articles by Nicolaides, K. H. Search for Related Content PubMed PubMed Citation Articles by Poon, L. C.Y. Articles by Nicolaides, K. H. Related Collections Other hypertension Clinical Studies Related Article

(Hypertension. 2009;53:812.)
© 2009 American Heart Association, Inc.

Original Articles

First-Trimester Prediction of Hypertensive Disorders in Pregnancy

Leona C.Y. Poon; Nikos A. Kametas; Nerea Maiz; Ranjit Akolekar; Kypros H. Nicolaides

From the Harris Birthright Research Centre for Fetal Medicine, King’s College Hospital, London, United Kingdom.

Correspondence to Kypros H. Nicolaides, Harris Birthright Research Centre for Fetal Medicine, King’s College Hospital, Denmark Hill, London SE5 9RS, United Kingdom. E-mail kypros{at}fetalmedicine.com

This study aimed to establish a method of screening for pregnancy hypertension by a combination of maternal variables, including mean arterial pressure, uterine artery pulsatility index, pregnancy-associated plasma protein-A, and placental growth factor in early pregnancy. The base-cohort population constituted of 7797 singleton pregnancies, including 34 case subjects who developed preeclampsia (PE) requiring delivery before 34 weeks (early PE) and 123 with late PE, 136 with gestational hypertension, and 7504 cases subjects (96.3%) who were unaffected by PE or gestational hypertension. Maternal history, uterine artery pulsatility index, mean arterial pressure, and pregnancy-associated plasma protein-A were recorded in all of the cases in the base cohort, but placental growth factor was measured only in the case-control population of 209 cases who developed hypertensive disorders and 418 controls. In each case the measured mean arterial pressure, uterine artery pulsatility index, pregnancy-associated plasma protein-A, and placental growth factor were converted to a multiple of the expected median (MoM) after correction for maternal characteristics found to affect the measurements in the unaffected group. Early PE and late PE were associated with increased mean arterial pressure (1.15 MoM and 1.08 MoM) and uterine artery pulsatility index (1.53 MoM and 1.23 MoM) and decreased pregnancy-associated plasma protein-A (0.53 MoM and 0.93 MoM) and placental growth factor (0.61 MoM and 0.83 MoM). Logistic regression analysis was used to derive algorithms for the prediction of hypertensive disorders. It was estimated that, with the algorithm for early PE, 93.1%, 35.7%, and 18.3% of early PE, late PE, and gestational hypertension, respectively, could be detected with a 5% false-positive rate and that 1 in 5 pregnancies classified as being screen positive would develop pregnancy hypertension. This method of screening is far superior to the traditional approach, which relies entirely on maternal history.

Key Words: first-trimester screening • mean arterial pressure • uterine artery Doppler • PAPP-A • placental growth factor • preeclampsia

Related Article:

First-Trimester Prediction of Early Preeclampsia: A Possibility at Last!

Richard J. Levine and Marshall D. Lindheimer
Hypertension 2009 53: 747-748. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				R. J. Levine and M. D. Lindheimer First-Trimester Prediction of Early Preeclampsia: A Possibility at Last! Hypertension, May 1, 2009; 53(5): 747 - 748. [Full Text] [PDF]